60 Degrees Pharmaceuticals, Inc. Common Stock share price logo

60 Degrees Pharmaceuticals, Inc. Common Stock

NASDAQ: SXTP

Small Cap

$1.50

Live

as on

60 Degrees Pharmaceuticals, Inc. Common Stock Stock Performance

as on May 14, 2026 at 4:08 am IST

  • Day's Low

    $1.47
    $1.50
    downward going graph

    2.00%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.29
    $14.68
    downward going graph

    14.00%

    Downside

    878.67%

    Upside

    downward going graph

60 Degrees Pharmaceuticals, Inc. Common Stock share price movements today

Previous Close
$1.50
Open
$1.48
Volume
216.6K
Day's Low - High
$1.47 - $1.50
52 Week Low - High
$1.29 - $14.68

60 Degrees Pharmaceuticals, Inc. Common Stock Historical Returns

1 Month Return
-22.68 %
3 Month Return
-57.26 %
1 Year Return
-84.31 %
3 Year Return
0 %
5 Year Return
0 %

60 Degrees Pharmaceuticals, Inc. Common Stock Stock Fundamentals & Key Indicators

Check 60 Degrees Pharmaceuticals, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.9M

EPS (TTM)

-3.18

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-7.7M

Revenue (TTM)

1.4M

Profit Margin

0.00%

Return On Equity TTM

-200.92%

60 Degrees Pharmaceuticals, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 60 Degrees Pharmaceuticals, Inc. Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
60 Degrees Pharmaceuticals, Inc. Common Stock image
60 Degrees Pharmaceuticals, Inc. Common Stock
BUY$3.9MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$38.0B119.7%71.3912.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA71.448.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.4B109.14%25.8435.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.7B39.88%17.3929.65%

Stock Returns calculator for 60 Degrees Pharmaceuticals, Inc. Common Stock Stock including INR - Dollar returns

The 60 Degrees Pharmaceuticals, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

60 Degrees Pharmaceuticals, Inc. Common Stock investment value today

Current value as on today

₹17,610

Returns

-₹82,390

(-82.39%)

Returns from 60 Degrees Pharmaceuticals, Inc. Common Stock Stock

-₹84,310 (-84.31%)

Dollar Impact

₹1,919 (+1.92%)

Analyst Recommendation on 60 Degrees Pharmaceuticals, Inc. Common Stock Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for 60 Degrees Pharmaceuticals, Inc. Common Stock. Average target price of $14.1

60 Degrees Pharmaceuticals, Inc. Common Stock Share Price Target

Get share price movements and forecasts by analysts on 60 Degrees Pharmaceuticals, Inc. Common Stock.

What analysts predicted

89.36%UPSIDE

Target Price

$14.1

Current Price

$1.5

Analyzed by

8 Analysts

Target

$14.10

60 Degrees Pharmaceuticals, Inc. Common Stock target price $14.1, a slight upside of 89.36% compared to current price of $1.5. According to 8 analysts rating.

Indian Investors' Interest in 60 Degrees Pharmaceuticals, Inc. Common Stock Stock

Search interest for 60 Degrees Pharmaceuticals, Inc. Common Stock Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-47% versus previous 30 day period

60 Degrees Pharmaceuticals, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-1
-1
-1
-4
-2
-2
-1
-1
-2
-1
EBITDA
4
-1
0
-4
-2
-2
-1
-1
-2
-1
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
4
-2
0
-4
-2
-2
-1
-1
-2
-1
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
4
-1
0
-4
-2
-2
-1
-1
-2
-1
Net Profit Margin
8172.22%
-4584.98%
407.36%
-3338.95%
-1596.38%
-783.65%
-1147.37%
-1717.72%
-529.48%
-474.98%

60 Degrees Pharmaceuticals, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
1
0
0
0
1
Gross Profit
1
0
0
0
0
0
Operating Income
0
-1
-1
-5
-9
-7
EBITDA
0
-1
-2
-1
-7
-7
Interest Expense
2
3
3
2
0
0
Depreciation
0
0
0
0
0
0
Income Before Tax
-3
-4
-6
-3
-7
-7
Income Tax Expense
0
0
0
0
0
-
Net Income
-3
-4
-6
-3
-7
-7
Net Profit Margin
-139.08%
-366.42%
-2769.49%
-1485.06%
-1308.01%
-732.82%

60 Degrees Pharmaceuticals, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-1
0
-4
-2
-2
-1
-1
-2
-1
Operating Cash Flow
0
-1
-1
-1
-1
-1
-1
-2
-1
Investing Cash Flow
-
0
0
-1
0
1
0
0
-1
Financing Cash Flow
0
1
0
5
0
1
-
4
0
Change in Cash
0
0
-1
1
-1
1
-1
2
-2

60 Degrees Pharmaceuticals, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-6
-3
-7
-7
Operating Cash Flow
0
-1
-4
-5
-6
Investing Cash Flow
0
0
0
-1
0
Financing Cash Flow
0
1
6
7
6
Change in Cash
0
0
1
0
0

Insights on 60 Degrees Pharmaceuticals, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -2.31M → -1.44M (in $), with an average increase of 60.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 124.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SXTP stock has moved down by -22.7%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 437.60K → 303.38K (in $), with an average decrease of 30.7% per quarter

About 60 Degrees Pharmaceuticals, Inc. Common Stock

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia.
Organisation60 Degrees Pharmaceuticals, Inc. Common Stock
Headquarters1025 Connecticut Avenue NW, Washington, DC, United States, 20036
IndustryBiotechnology
CEODr. Geoffrey Stuart Dow Ph.D.
E-voting on sharesClick here to vote

Key Management of 60 Degrees Pharmaceuticals, Inc. Common Stock

Name

Title

Mr. Tyrone Miller

CFO & Treasurer

Ms. Kristen Landon

Chief Commercial Officer

Dr. Bryan Smith

Chief Medical Officer

Dr. Geoffrey Stuart Dow Ph.D.

Chairman, CEO & President

FAQs

What is 60 Degrees Pharmaceuticals, Inc. Common Stock share price today?

60 Degrees Pharmaceuticals, Inc. Common Stock share price today is $1.5 as on . 60 Degrees Pharmaceuticals, Inc. Common Stock share today touched a day high of $1.5 and a low of $1.47.

What is the 52 week high and 52 week low for 60 Degrees Pharmaceuticals, Inc. Common Stock share?

60 Degrees Pharmaceuticals, Inc. Common Stock share touched a 52 week high of $14.68 on and a 52 week low of $1.29 on . 60 Degrees Pharmaceuticals, Inc. Common Stock stock price today i.e. is trending at $1.5,which is 89.78% down from its 52 week high and 16.28% up from its 52 week low.

What is 60 Degrees Pharmaceuticals, Inc. Common Stock's market capitalisation today?

60 Degrees Pharmaceuticals, Inc. Common Stock market capitalisation is $0.00T as on .

How to invest in 60 Degrees Pharmaceuticals, Inc. Common Stock Stock (SXTP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for 60 Degrees Pharmaceuticals, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 60 Degrees Pharmaceuticals, Inc. Common Stock Shares that will get you 1.0000 shares as per 60 Degrees Pharmaceuticals, Inc. Common Stock share price of $1.5 per share as on May 13, 2026 at 10:38 pm IST.

What is the minimum amount required to buy 60 Degrees Pharmaceuticals, Inc. Common Stock Stock (SXTP) from India?

Indian investors can start investing in 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in 60 Degrees Pharmaceuticals, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on 60 Degrees Pharmaceuticals, Inc. Common Stock share’s latest price of $1.5 as on May 13, 2026 at 10:38 pm IST, you will get 6.6667 shares of 60 Degrees Pharmaceuticals, Inc. Common Stock. Learn more about fractional shares .